We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CADL icon
11501
Candel Therapeutics
CADL
$897M
$53K ﹤0.01%
+16,851
New +$57.1K
CMMB
11502
Chemomab Therapeutics
CMMB
$14M
$53K ﹤0.01%
+5,307
New +$68.4K
LVWR.WS icon
11503
LiveWire Group Warrants
LVWR.WS
$6.88M
$53K ﹤0.01%
+150,097
New +$55.9K
MNOV icon
11504
MediciNova
MNOV
$64.5M
$53K ﹤0.01%
24,527
-4,606
-16% -$10.7K
PDSB icon
11505
PUT
PDS Biotechnology
PDSB
$12.9M
$53K ﹤0.01%
17,900
-71,500
-80% -$303K
TBLA icon
11506
PUT
Taboola.com
TBLA
$1.09B
$53K ﹤0.01%
29,400
+13,400
+84% +$34.5K
VNRX icon
11507
CALL
VolitionRx Ltd
VNRX
$6.89M
$53K ﹤0.01%
1,960
+610
+45% +$23.1K
ASXC
11508
CALL
DELISTED
Asensus Surgical, Inc.
ASXC
$53K ﹤0.01%
117,800
+13,600
+13% +$7.09K
VIEW
11509
CALL
DELISTED
View, Inc. Class A Common Stock
VIEW
$53K ﹤0.01%
655
-35
-5% -$3.98K
SLGC
11510
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$53K ﹤0.01%
18,332
-1,028,550
-98% -$4.33M
ZEV
11511
PUT
DELISTED
Lightning eMotors, Inc.
ZEV
$53K ﹤0.01%
1,715
-540
-24% -$30.8K
SCUA.WS
11512
DELISTED
Sculptor Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SCUA.WS
$53K ﹤0.01%
375,152
+80,141
+27% +$13.9K
ATIP
11513
PUT
DELISTED
ATI Physical Therapy, Inc.
ATIP
$53K ﹤0.01%
1,066
-88
-8% -$5.01K
AXDX
11514
CALL
DELISTED
Accelerate Diagnostics
AXDX
$52K ﹤0.01%
3,430
+440
+15% +$7.28K
EMX
11515
DELISTED
EMX Royalty
EMX
$52K ﹤0.01%
27,946
+10,557
+61% +$19.9K
GDC icon
11516
GD Culture Group
GDC
$7.74M
$52K ﹤0.01%
44
+36
+450% +$87.8K
LTRX icon
11517
CALL
Lantronix
LTRX
$289M
$52K ﹤0.01%
+10,800
New +$65.6K
PLBY icon
11518
Playboy Inc
PLBY
$151M
$52K ﹤0.01%
+12,699
New +$68.2K
RVPH
11519
PUT
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$52K ﹤0.01%
+1,625
New +$44.9K
UAVS icon
11520
CALL
AgEagle Aerial Systems
UAVS
$63.9M
$52K ﹤0.01%
111
-45
-29% -$27.9K
VRCA icon
11521
CALL
Verrica Pharmaceuticals
VRCA
$85.4M
$52K ﹤0.01%
1,790
+290
+19% +$9.94K
AKTS
11522
DELISTED
Akoustis Technologies Inc
AKTS
$52K ﹤0.01%
17,417
-28,638
-62% -$116K
HYZN
11523
PUT
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$52K ﹤0.01%
614
-190
-24% -$24.9K
FREE
11524
PUT
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$52K ﹤0.01%
+13,600
New +$74.1K
EQRX
11525
CALL
DELISTED
EQRx, Inc. Common Stock
EQRX
$52K ﹤0.01%
10,600
-55,700
-84% -$281K

Similar funds

Ken Griffin's Q3 2022 Portfolio in Review

As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
  • Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.